Core Laboratories Inc. Common Stock (CLB)
12.02
-1.42 (-10.57%)
NYSE · Last Trade: Apr 5th, 6:58 AM EDT
Detailed Quote
Previous Close | 13.44 |
---|---|
Open | 12.75 |
Bid | 11.60 |
Ask | 12.44 |
Day's Range | 11.65 - 12.96 |
52 Week Range | 11.49 - 25.13 |
Volume | 377,147 |
Market Cap | 560.91M |
PE Ratio (TTM) | 23.57 |
EPS (TTM) | 0.5 |
Dividend & Yield | 0.0400 (0.33%) |
1 Month Average Volume | 399,000 |
Chart
About Core Laboratories Inc. Common Stock (CLB)
Core Laboratories Inc is a leading provider of proprietary and patented reservoir optimization services and products designed to enhance the efficiency and economic viability of oil and gas exploration and production. The company specializes in advanced technology solutions for reservoir characterization, production enhancement, and asset management, offering a comprehensive range of laboratory services that support both conventional and unconventional energy development. By leveraging its expertise in petrophysics, geology, and engineering, Core Laboratories assists energy companies in maximizing recovery rates and extending the life of reservoirs, ultimately contributing to sustainable resource management in the energy sector. Read More
News & Press Releases

Via Benzinga · March 12, 2025

CLB earnings call for the period ending December 31, 2024.
Via The Motley Fool · January 30, 2025

Via Benzinga · December 23, 2024

Shares of Rumble Inc.
Via Benzinga · December 23, 2024

CLB earnings call for the period ending June 30, 2023.
Via The Motley Fool · July 27, 2023

CLB earnings call for the period ending September 30, 2024.
Via The Motley Fool · October 24, 2024

CLB earnings call for the period ending June 30, 2024.
Via The Motley Fool · July 25, 2024

CLB stock results show that Core Laboratories beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · July 24, 2024

Executives from a Range of Industries to Present to 300+ Institutional Investors and Analysts in San Francisco on September 4-5, 2024
By Gateway Group · Via GlobeNewswire · July 16, 2024

Via Benzinga · April 25, 2024

CLB stock results show that Core Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · April 24, 2024

Cannabis multi-state operator Cresco Labs kicked off February by announcing the promotion of Greg Butler to the position of president. Tom Shuman, a CPG sales and marketing veteran, agreed to serve as The Hempshire Group's new CEO. Los Angeles-based STIIIZY INC. named Isaac Kim its new CFO earlier this month. Another California-based cannabis operator Lowell Farms appointed Jamie Schniedwind as its new director of finance. The Colorado-based medical cannabis pioneer Charlotte's Web Holdings tapped Matthew E. McCarthy, the former CEO of Ben & Jerry's Homemade, to serve on its board earlier this month. Aurora Cannabis has named Simona King, a former executive of Bristol Myers-Squibb, its new CFO.
Via Benzinga · February 20, 2024

CLB earnings call for the period ending December 31, 2023.
Via The Motley Fool · February 1, 2024

Discover the hidden pitfalls in the investment world with a deep dive into these three stocks to sell now to protect your portfolio.
Via InvestorPlace · January 9, 2024

You have until the end of the month to dump these oil stocks before they crash. Do you have these three in your portfolio?
Via InvestorPlace · January 2, 2024

CLB earnings call for the period ending September 30, 2023.
Via The Motley Fool · November 2, 2023

Halliburton’s commitment to technological innovation is a differentiator — and its undervalued stock a potential opportunity for long-term investors.
Via MarketBeat · October 16, 2023

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
Via Benzinga · January 31, 2024

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Monday. Here are some big stocks recording gains in today’s session.
Via Benzinga · October 9, 2023

Halliburton Company (NYSE: HAL) and Core Laboratories Inc. (NYSE: CLB) announced a strategic alliance aimed at expediting the delivery of
Via Benzinga · October 9, 2023

Via Benzinga · June 30, 2023